Autologous Bone-Marrow Mononuclear Cell Implantation Improves Endothelium-Dependent Vasodilation in Patients with Limb Ischemia

Circulation

Volumn 109, Issue 10, 2004, Pages 1215-1218

  Higashi, Yukihito ^a,d   Kimura, Masashi ^a   Hara, Keiko ^a   Noma, Kensuke ^a   Jitsuiki, Daisuke ^a   Nakagawa, Keigo ^a   Oshima, Tetsuya ^a   Chayama, Kazuaki ^a   Sueda, Taijiro ^a   Goto, Chikara ^a   Matsubara, Hiroaki ^b   Murohara, Toyoaki ^c   Yoshizumi, Masao ^a  

^a HIROSHIMA UNIVERSITY   (Japan)

^b KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^c NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^d HIROSHIMA UNIVERSITY   (Japan)

Author keywords

Angiogenesis; Cells; Endothelium; Ischemia

Indexed keywords

ACETYLCHOLINE; NITROPRUSSIDE SODIUM; SILASTIC; VASODILATOR AGENT;

ADULT; AGED; ARTICLE; BONE MARROW TRANSPLANTATION; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; FEMALE; HUMAN; HUMAN CELL; LEG BLOOD FLOW; LIMB ISCHEMIA; MALE; MONONUCLEAR CELL; PLETHYSMOGRAPHY; PRIORITY JOURNAL; TRANSCUTANEOUS OXYGEN MONITORING; VASODILATATION;

ACETYLCHOLINE; AGED; BONE MARROW CELLS; BONE MARROW TRANSPLANTATION; COLLATERAL CIRCULATION; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; ISCHEMIA; LEG; MALE; MIDDLE AGED; NITROPRUSSIDE; PERIPHERAL VASCULAR DISEASES; PLETHYSMOGRAPHY; TREATMENT OUTCOME; VASODILATOR AGENTS;

EID: 12144290182     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.0000121427.53291.78     Document Type: Article

References (13)

1. Shintani S, Murohara T, Ikeda H, et al. Augmentation of postnatal neovascularization with autologous bone marrow transplantation. Circulation. 2001;103:897-895.
2. Tateishi-Yuyama E, Matsubara H, Murohara T, et al. Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: a pilot study and a randomized controlled trial. Lancet. 2002;360:427-435.
3. Ross R. The pathogenesis of atherosclerosis. N Engl J Med. 1999;340:115-126.
4. Boger RH, Bode-Boger SM, Brandes R, et al. Biochemical evidence for impaired nitric oxide synthase in patients with peripheral arterial occlusive disease. Circulation. 1997;95:2068-2074.
5. I21 improves lower-extremity endothelial function and flow reserve. Circulation. 2001;104:753-755.
6. Panza JA, Quyyumi AA, Brush JE Jr, et al. Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension. N Engl J Med. 1990;323:22-27.
7. Higashi Y, Sasaki S, Nakagawa K, et al. Endothelial function and oxidative stress in renovascular hypertension. N Engl J Med. 2002;346:1954-1962.
8. Miller VM, Vanhoutte PM. Enhanced release of endothelium-derived factors by chronic increases in blood flow. Am J Physiol. 1988;255: H446-H451.
9. Uematsu M, Ohara Y, Navas JP, et al. Regulation of endothelial cell nitric oxide synthase mRNA expression by shear stress. Am J Physiol. 1995;269:C1371-C1378.
10. Asahara T, Murohara T, Sullivan A, et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science. 1997;275:964-967.
11. Bauters C, Asahara T, Zheng LP, et al. Recovery of disturbed endothelium-dependent flow in the collateral-perfused rabbit ischemic hindlimb after administration of vascular endothelial growth factor. Circulation. 1995;91:2802-2809.
12. Shen B-Q, Lee DY, Zioncheck TZ. Vascular endothelial growth factor governs endothelial nitric-oxide synthase expression via a KDR/FLK-1 receptor and a protein kinase C signaling pathway. J Biol Chem. 1999;274:33057-33063.
13. Higashi Y, Sasaki S, Nakagawa K, et al. The severity of hypertension affects improved resistance artery endothelial function by angiotensin converting enzyme inhibition. J Cardiovasc Pharmacol. 2002;39:668-676.